Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From PAtients to Neuromuscular Organoids in Refractory AChR+ Myasthenia grAvis: End-plate Dysfunction, Biomarker Discovery and Regeneration Strategies

NCT07717281 is registered in ClinicalTrials.gov with Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07717281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From PAtients to Neuromuscular Organoids in Refractory AChR+ Myasthenia grAvis: End-plate Dysfunction, Biomarker Discovery and Regeneration Strategies
Lead sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase
Observational
Overall status
Recruiting
Start date
June 4, 2026
Completion date
March 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis generalized